Log in
Enquire now
‌

US Patent 8383367 IL-21 variant nucleic acids

Patent 8383367 was granted and assigned to Novo Nordisk on February, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
Novo Nordisk
Novo Nordisk
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8383367
Date of Patent
February 26, 2013
Patent Application Number
13236163
Date Filed
September 19, 2011
Patent Citations Received
‌
US Patent 12122827 IL-21 polypeptides and targeted constructs
0
‌
US Patent 12012441 Engineered human IL-21 cytokines and methods for using the same
0
‌
US Patent 12024559 Fusions with CD8 antigen binding molecules for modulating immune cell function
0
Patent Primary Examiner
‌
Dong Jiang
Patent abstract

IL-21 variants nucleic acid sequences are provided that encode a peptide having deletions and zero to ten conservative amino acid substitutions in the region of amino acid residues 65-96 of SEQ ID. NO:2.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8383367 IL-21 variant nucleic acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.